Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Straub

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Environmental Toxicology and Chemistry|June 12, 2014
Rational selection of alternative, environmentally compatible surfactants for biotechnological production of pharmaceuticals--a step toward green biotechnologyJürg Oliver Straub, Russel Shearer, Martin Studer
Environmental Toxicology and Chemistry|June 22, 2019
Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface WatersJürg Oliver Straub, Rik Oldenkamp, Thomas Pfister, et al.
Journal of Computational Neuroscience|April 22, 2008
Motor pattern selection by combinatorial code of interneuronal pathwaysWolfgang Stein, Oliver Straub, Jessica Ausborn, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|November 27, 2009
Mixture toxicity of the antiviral drug Tamiflu((R)) (oseltamivir ethylester) and its active metabolite oseltamivir acidBeate I Escher, Nadine Bramaz, Judit Lienert, et al.
Environmental Toxicology and Chemistry|December 23, 2011
Environmental risk assessment for ancillary substances in biotechnological production of pharmaceuticalsJürg Oliver Straub, Daniel Gysel, Ursula Kastl, et al.
Bioresource Technology|January 24, 2017
Performance of an anaerobic membrane bioreactor for pharmaceutical wastewater treatmentJan Svojitka, Lukáš Dvořák, Martin Studer, et al.
Plos One|November 12, 2021
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathologyAlcibiade Athanasiou, Pierre Tennstedt, Anja Wittig, et al.
Environment International|April 28, 2009
Extending the environmental risk assessment for oseltamivir (Tamiflu) under pandemic use conditions to the coastal marine compartmentThomas H Hutchinson, Amanda Beesley, Patricia E Frickers, et al.
Chimia|March 22, 2020
Assessment, Pretreatment and Treatment of Pharmaceutical Production Wastewaters in the Roche GroupJürg Oliver Straub, Christoph Acklin, Jürgen Klemmer, et al.
Chemosphere|November 20, 2018
Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fateJürg Oliver Straub, Daniel J Caldwell, Todd Davidson, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Environmental Toxicology and Chemistry|June 12, 2014
Rational selection of alternative, environmentally compatible surfactants for biotechnological production of pharmaceuticals--a step toward green biotechnologyJürg Oliver Straub, Russel Shearer, Martin Studer
Environmental Toxicology and Chemistry|June 22, 2019
Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface WatersJürg Oliver Straub, Rik Oldenkamp, Thomas Pfister, et al.
Journal of Computational Neuroscience|April 22, 2008
Motor pattern selection by combinatorial code of interneuronal pathwaysWolfgang Stein, Oliver Straub, Jessica Ausborn, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|November 27, 2009
Mixture toxicity of the antiviral drug Tamiflu((R)) (oseltamivir ethylester) and its active metabolite oseltamivir acidBeate I Escher, Nadine Bramaz, Judit Lienert, et al.
Environmental Toxicology and Chemistry|December 23, 2011
Environmental risk assessment for ancillary substances in biotechnological production of pharmaceuticalsJürg Oliver Straub, Daniel Gysel, Ursula Kastl, et al.
Bioresource Technology|January 24, 2017
Performance of an anaerobic membrane bioreactor for pharmaceutical wastewater treatmentJan Svojitka, Lukáš Dvořák, Martin Studer, et al.
Plos One|November 12, 2021
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathologyAlcibiade Athanasiou, Pierre Tennstedt, Anja Wittig, et al.
Environment International|April 28, 2009
Extending the environmental risk assessment for oseltamivir (Tamiflu) under pandemic use conditions to the coastal marine compartmentThomas H Hutchinson, Amanda Beesley, Patricia E Frickers, et al.
Chimia|March 22, 2020
Assessment, Pretreatment and Treatment of Pharmaceutical Production Wastewaters in the Roche GroupJürg Oliver Straub, Christoph Acklin, Jürgen Klemmer, et al.
Chemosphere|November 20, 2018
Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fateJürg Oliver Straub, Daniel J Caldwell, Todd Davidson, et al.
Pageof 3